Symptomatic crystalluria associated with indinavir

Annals of Pharmacotherapy

Volumn 34, Issue 12, 2000, Pages 1414-1418

  Famularo, Giuseppe ^a   Di Toro, Stefania ^a   Moretti, Sonia ^a   De Simone, Claudio ^b  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Crystalluria; Indinavir; Stones; Urinary tract disease

Indexed keywords

CIPROFLOXACIN; CITRIC ACID; DICLOFENAC; INDINAVIR;

ADULT; ARTICLE; CASE REPORT; CRYSTALLURIA; DOSE RESPONSE; DRUG EXCRETION; DRUG INDUCED DISEASE; FEMALE; FLUID INTAKE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FUNCTION; PRIORITY JOURNAL; URINALYSIS; URINARY TRACT OBSTRUCTION; URINE ACIDIFICATION; UROLITHIASIS; VIRUS RESISTANCE;

ADULT; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; INDINAVIR; KIDNEY CALCULI; UROLOGIC DISEASES;

EID: 0033634726     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.10092     Document Type: Article

References (26)

1. Crystal-induced acute renal failure
2. Crystalluria and urinary tract abnormalities associated with indinavir
3. Urinary stones in HIV-1-positive patients treated with indinavir
4. Indinavir nephropathy
5. Indinavir nephropathy in an AIDS patient with renal insufficiency and pyuria
6. Variation in incidence of indinavir-associated nephrolithiasis among HIV-positive patients
7. Indinavir sulfate renal toxicity in a pediatric hemophiliac with HIV infection
8. Protease inhibitor therapy in children with perinatally acquired HIV infection
9. A method for estimating the probability of adverse drug reactions
10. Treatment of complicated renal colic in patients with indinavir: Value of double J stents
11. Urolithiasis associated with protease inhibitors
12. Indinavir urolithiasis: An emerging cause of renal colic in patients with human immunodeficiency virus
13. Frequency of urolithiasis in individuals seropositive for human immunodeficiency virus treated with indinavir is higher than previously assumed
14. Urolithiasis and the protease inhibitor indinavir
15. Protease inhibitor-induced urolithiasis
16. Imaging characteristics of indinavir calculi
17. Nonopaque crystal deposition causing ureteric obstruction in patients with HIV undergoing indinavir therapy
18. Urological complaints in relation to indinavir plasma concentrations in HIV-infected patients
19. Indinavir crystallization and urolithiasis
20. pH-dependent oral absorption of L-735,524, a potent HIV-1 protease inhibitor, in rats and dogs
21. Urolithiasis associated with the protease inhibitor indinavir
22. Antiretroviral therapy in adults. Updated recommendations of the International AIDS Society-USA panel
23. Indinavir nephrolithiasis in warm climates
24. Changes in renal function associated with indinavir
25. Indinavir and interstitial nephritis
26. Indinavir-induced nephropathy